UPDATE

UPDATES from DIA 2012: "Collaborate to innovate," says the association

By Natalie Morrison

- Last updated on GMT

Related tags: Pharmacology, Clinical trial, Clinical research

UPDATES from DIA 2012: collaborative drug development
“Collaborate to innovate,” is the message DIA has for clinical researchers at its 2012 Annual Meeting in Philadelphia, US.

On Monday organisation opened the doors to its conference, and already Twitter has been flooded with news and views about drug development and how the DIA (Drug Information Association) is involved.

As always, the need for more innovation is a crucial issue, and better trial management systems is also a subject close to many’s hearts, with ethics in emerging markets, IRBs (institutional review boards), and paediatrics as some of the big topics.

Outsourcing-Pharma.com presents the cream of the crop as the show goes on…

Related news

Show more

Related products

show more

Stability Testing As a Quality Control Measure

Stability Testing As a Quality Control Measure

Frontage Laboratories | 19-Jun-2019 | Technical / White Paper

Stability testing is, in essence, a quality control process and is there¬fore a vital component of every phase of clinical development for both large and...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 05-Nov-2018 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Baxter’s Oncology Contract Manufacturing

Baxter’s Oncology Contract Manufacturing

Baxter BioPharma Solutions | 29-Aug-2018 | Product Brochure

Baxter BioPharma Solutions’ FOYA award-winning facility in Halle/Westfalen, Germany, offers state-of-the-art parenteral cGMP manufacturing at one location,...

Related suppliers

Follow us

Products

View more

Webinars